Mon. 13 May 2024, 7:02am ET
Benzinga
Earnings, Earnings Beats, Earnings Misses, News
Legend Biotech (NASDAQ:LEGN) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.34) by 52.94 percent. This is a 52.94 percent increase over losses of $(0.34) per share from the same period last year. The company reported quarterly sales of $93.991 million which missed the analyst consensus estimate of $152.631 million by 38.42 percent. This is a 158.67 percent increase over sales of $36.336 million the same period last year.